With AI becoming more prevalent in the pharma space, Raman Bhatnagar, Pharmaceuticals lead, Aspen Technology, explores the power of machine learning and analytics, and how this helps anticipate failure prediction in pharma manufacturing.
BD and Biocorp joined forces to improve the outcomes and adherence of self-administered drugs through connected drug delivery, by combining the use of digital technology with prefillable syringes.
EPM held a Q&A session with Vincent Rolland, Idorsia Pharmaceuticals, and Richard Young, Veeva, to discuss how investing in digital data management can benefit biopharma, from clinical trials through to market.
Kari Miller, sr. director, Product Management, SmartSolve, IQVIA explores why purpose-built QMS technology is necessary for the life science industry, from mitigating risk to maintaining regulatory compliance.
Mark Gregory, chief pharmacy officer for Pleio, focuses on pharmacy services as a component of healthcare delivery, and the power of the human connection in optimising pharmacy’s digital transformation.
Kry is expanding its chronic disease management and population health solutions with the launch of new treatment pathways for obesity. Through boosting access, Kry hopes to keep patients healthier for longer, reducing the need for medical treatments.
Pippa White, senior global account director for Life Sciences at SAS, explores the reservations many in the life sciences industry have and highlights why now is the time to embrace analytics in the cloud.
Kelly Doering, senior director Industry Marketing, Pharma, AspenTech, explores how pharmaceutical manufacturing should embrace change in its methods and solutions to stand out in an ever-advancing field.
Richard Young, vice president of Vault CDMS - Veeva Systems gives EPM some insight how a centralised data strategy can effectively manage clinical data.
For pharmaceuticals manufacturers, progressing digitalisation and moving to the cloud has been notoriously slow, and misperceptions of what moving to the cloud entails have been a significant factor in this lack of adoption.
